Noninvasive evaluation of airway inflammation in patients with severe asthma

Annals of Allergy, Asthma and Immunology

Volumn 110, Issue 5, 2013, Pages 316-321

  Papaporfyriou, Anastasia ^a   Tseliou, Eleni ^a   Loukides, Stelios ^a   Kostikas, Konstantinos ^a   Bakakos, Petros ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; EOTAXIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROGEN PEROXIDE; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 5; INTERLEUKIN 8; ISOPROSTANE DERIVATIVE; LEUKOTRIENE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OSTEOPONTIN; PEPTIDOLEUKOTRIENE; TRANSFORMING GROWTH FACTOR BETA1;

ASTHMA; CLINICAL EVALUATION; CYTOKINE RELEASE; DISEASE SEVERITY; DRUG MEGADOSE; EOSINOPHIL COUNT; EXHALED BREATH CONDENSATE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATORY CELL; LEUKOCYTE DIFFERENTIAL COUNT; NON INVASIVE PROCEDURE; PH MEASUREMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; REVIEW; SAFETY; SPUTUM INDUCTION; SPUTUM LEVEL; TREATMENT RESPONSE; VALIDITY;

ASTHMA; BREATH TESTS; EXHALATION; HUMANS; NITRIC OXIDE; PNEUMONIA; SPUTUM;

EID: 84876531634     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2012.12.026     Document Type: Review

References (60)

1. E.H. Bel, A. Sousa, and L. Fleming Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI) Thorax 66 2011 910 917
2. R. Louis, and V. Potmans Analysis of induced sputum in refractory asthma Presse Med 37 2008 155 159
3. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society Am J Respir Crit Care Med 162 2000 2341 2351
4. I. Pin, P.G. Gibson, and R. Kolendowicz Use of induced sputum cell counts to investigate airway inflammation in asthma Thorax 47 1992 25 29
5. R. Djukanovic, P.J. Sterk, and J.V. Fahy Standardised methodology of sputum induction and processing Eur Respir J Suppl 37 2002 1s 2s
6. A. Efthimiadis, A. Spanevello, and Q. Hamid Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation Eur Respir J Suppl 37 2002 19s 23s
7. J.L. Simpson, R. Scott, and M.J. Boyle Inflammatory subtypes in asthma: assessment and identification using induced sputum Respirology 11 2006 54 61
8. S.E. Wenzel, L.B. Schwartz, and E.L. Langmack Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics Am J Respir Crit Care Med 160 1999 1001 1008
9. R. Louis, L.C. Lau, and A.O. Bron The relationship between airways inflammation and asthma severity Am J Respir Crit Care Med 161 2000 9 16
10. F.E. Hargreave, E. Pizzichini, and M. Pizzichini Induced sputum examination J Allergy Clin Immunol 101 1998 569 570
11. L. Jayaram, K. Parameswaran, and M.R. Sears Induced sputum cell counts: their usefulness in clinical practice Eur Respir J 16 2000 150 158
12. A. ten Brinke, A.H. Zwinderman, and P.J. Sterk "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids Am J Respir Crit Care Med 170 2004 601 605
13. M. Romagnoli, I. Vachier, and P. Tarodo de la Fuente Eosinophilic inflammation in sputum of poorly controlled asthmatics Eur Respir J 20 2002 1370 1377
14. M.L. Bartoli, E. Bacci, and S. Carnevali Clinical assessment of asthma severity partially corresponds to sputum eosinophilic airway inflammation Respir Med 98 2004 184 193
15. R.H. Green, C.E. Brightling, and S. McKenna Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial Lancet 360 2002 1715 1721
16. P. Haldar, I.D. Pavord, and D.E. Shaw Cluster analysis and clinical asthma phenotypes Am J Respir Crit Care Med 178 2008 218 224
17. P. Haldar, C.E. Brightling, and B. Hargadon Mepolizumab and exacerbations of refractory eosinophilic asthma N Engl J Med 360 2009 973 984
18. J.V. Fahy, K.W. Kim, and J. Liu Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation J Allergy Clin Immunol 95 1995 843 852
19. I.D. Pavord, C.E. Brightling, and G. Woltmann Non-eosinophilic corticosteroid unresponsive asthma Lancet 353 1999 2213 2214
20. S.E. Wenzel, S.J. Szefler, and D.Y. Leung Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids Am J Respir Crit Care Med 156 1997 737 743
21. A. Jatakanon, C. Uasuf, and W. Maziak Neutrophilic inflammation in severe persistent asthma Am J Respir Crit Care Med 160 1999 1532 1539
22. P.G. Gibson, J.L. Simpson, and N. Saltos Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8 Chest 119 2001 1329 1336
23. A. ten Brinke, A.H. Zwinderman, and P.J. Sterk Factors associated with persistent airflow limitation in severe asthma Am J Respir Crit Care Med 164 2001 744 748
24. J. Shannon, P. Ernst, and Y. Yamauchi Differences in airway cytokine profile in severe asthma compared to moderate asthma Chest 133 2008 420 426
25. D.E. Shaw, M.A. Berry, and B. Hargadon Association between neutrophilic airway inflammation and airflow limitation in adults with asthma Chest 132 2007 1871 1875
26. European Network for Understanding Mechanisms of Severe Asthma. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma Eur Respir J 22 2003 470 477
27. P. Chanez, S.E. Wenzel, and G.P. Anderson Severe asthma in adults: what are the important questions? J Allergy Clin Immunol 119 2007 1337 1348
28. M.A. Berry, B. Hargadon, and M. Shelley Evidence of a role of tumor necrosis factor alpha in refractory asthma N Engl J Med 354 2006 697 708
29. E. Truyen, L. Coteur, and E. Dilissen Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients Thorax 61 2006 202 208
30. A. Barczyk, W. Pierzchala, and E. Sozanska Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine Respir Med 97 2003 726 733
31. V. Delimpoura, P. Bakakos, and E. Tseliou Increased levels of osteopontin in sputum supernatant in severe refractory asthma Thorax 65 2010 782 786
32. E. Tseliou, P. Bakakos, and K. Kostikas Increased levels of angiopoietins 1 and 2 in sputum supernatant in severe refractory asthma Allergy 67 2010 396 402
33. L.M. Hamilton, C. Torres-Lozano, and S.M. Puddicombe The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma Clin Exp Allergy 33 2003 233 240
34. F.L. Dente, S. Carnevali, and M.L. Bartoli Profiles of proinflammatory cytokines in sputum from different groups of severe asthmatic patients Ann Allergy Asthma Immunol 97 2006 312 320
35. C. Nathan, and Q.W. Xie Nitric oxide synthases: roles, tolls, and controls Cell 78 1994 915 918
36. P.E. Silkoff, S.C. Erzurum, and J.O. Lundberg ATS workshop proceedings: exhaled nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate Proc Am Thorac Soc 3 2006 131 145
37. D.E. Shaw, M.A. Berry, and M. Thomas The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial Am J Respir Crit Care Med 176 2007 231 237
38. C. Lemiere, P. Ernst, and R. Olivenstein Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes J Allergy Clin Immunol 118 2006 1033 1039
39. P.E. Silkoff, A.M. Lent, and A.A. Busacker Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma J Allergy Clin Immunol 116 2005 1249 1255
40. A. Spanevello, M. Confalonieri, and F. Sulotto Induced sputum cellularity: reference values and distribution in normal volunteers Am J Respir Crit Care Med 162 2000 1172 1174
41. E. Tseliou, V. Bessa, and G. Hillas Exhaled nitric oxide and exhaled breath condensate pH in severe refractory asthma Chest 138 2010 107 113
42. S.A. Kharitonov, and P.J. Barnes Exhaled markers of pulmonary disease Am J Respir Crit Care Med 163 2001 1693 1722
43. I.H. van Veen, A. Ten Brinke, and P.J. Sterk Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma Eur Respir J 32 2008 344 349
44. R.A. Dweik, R.L. Sorkness, and S. Wenzel Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma Am J Respir Crit Care Med 181 2010 1033 1041
45. A.F. Gelb, R. Moridzadeh, and D.H. Singh In moderate-to-severe asthma patients monitoring exhaled nitric oxide during exacerbation is not a good predictor of spirometric response to oral corticosteroid J Allergy Clin Immunol 129 2012 1491 1498
46. I. Horvath, J. Hunt, and P.J. Barnes Exhaled breath condensate: methodological recommendations and unresolved questions Eur Respir J 26 2005 523 548
47. P. Montuschi Exhaled breath condensate analysis in patients with COPD Clin Chim Acta 356 2005 22 34
48. K. Kostikas, G. Papatheodorou, and K. Ganas pH in expired breath condensate of patients with inflammatory airway diseases Am J Respir Crit Care Med 165 2002 1364 1370
49. A.O. Paget-Brown, L. Ngamtrakulpanit, and A. Smith Normative data for pH of exhaled breath condensate Chest 129 2006 426 430
50. K. Kostikas, A. Koutsokera, and S. Papiris Exhaled breath condensate in patients with asthma: implications for application in clinical practice Clin Exp Allergy 38 2008 557 565
51. L. Liu, W.G. Teague, and S. Erzurum Determinants of exhaled breath condensate pH in a large population with asthma Chest 139 2011 328 336
52. F.L. Ricciardolo, A. Di Stefano, and F. Sabatini Reactive nitrogen species in the respiratory tract Eur J Pharmacol 533 2006 240 252
53. M. Corradi, P. Montuschi, and L.E. Donnelly Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases Am J Respir Crit Care Med 163 2001 854 858
54. T. Ueno, M. Kataoka, and A. Hirano Inflammatory markers in exhaled breath condensate from patients with asthma Respirology 13 2008 654 663
55. T. Hanazawa, S.A. Kharitonov, and P.J. Barnes Increased nitrotyrosine in exhaled breath condensate of patients with asthma Am J Respir Crit Care Med 162 2000 1273 1276
56. P. Montuschi, and P.J. Barnes Exhaled leukotrienes and prostaglandins in asthma J Allergy Clin Immunol 109 2002 615 620
57. K. Samitas, D. Chorianopoulos, and S. Vittorakis Exhaled cysteinyl-leukotrienes and 8-isoprostane in patients with asthma and their relation to clinical severity Respir Med 103 2009 750 756
58. S. Loukides, K. Kontogianni, and G. Hillas Exhaled breath condensate in asthma: from bench to bedside Curr Med Chem 18 2011 1432 1443
59. P. Nair, M.M. Pizzichini, and M. Kjarsgaard Mepolizumab for prednisone-dependent asthma with sputum eosinophilia N Engl J Med 360 2009 985 993
60. P. Bakakos, F. Schleich, and M. Alchanatis Induced sputum in asthma: from bench to bedside Curr Med Chem 18 2011 1415 1422